Cargando…

S148. DIFFERENTIAL NEURAL REWARD MECHANISMS IN TREATMENT RESPONSIVE AND TREATMENT RESISTANT SCHIZOPHRENIA

BACKGROUND: The significant proportion of schizophrenia patients refractory to treatment targeting the dopamine system suggests that more than one mechanism may cause psychotic symptoms. Reinforcement learning tasks have frequently been employed in schizophrenia to assess dopaminergic functioning an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanes, Lucy, Mouchlianitis, Elias, Collier, Tracy, Averbeck, Bruno, Shergill, Sukhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888006/ http://dx.doi.org/10.1093/schbul/sby018.935

Ejemplares similares

T164. NETWORK CONNECTIVITY SUPPORTING REWARD LEARNING DIFFERENTIALLY DISRUPTED IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Horne, Charlotte, et al.
Publicado: (2020)

Neuroimaging oxytocin modulation of social reward learning in schizophrenia
por: Mouchlianitis, Elias D., et al.
Publicado: (2022)

O6.8. GLUTAMATERGIC DYSFUCTION AND TREATMENT RESPONSE IN MINIMALLY TREATED AND CHRONIC SCHIZOPHRENIA PATIENTS
por: Mouchlianitis, Elias, et al.
Publicado: (2018)

The neural mechanisms of social reward in early psychosis
por: Fett, Anne-Kathrin J, et al.
Publicado: (2019)

White matter changes in treatment refractory schizophrenia: Does cognitive control and myelination matter?
por: Vanes, Lucy D., et al.
Publicado: (2018)

Cognitive control network connectivity differentially disrupted in treatment resistant schizophrenia
por: Horne, Charlotte M., et al.
Publicado: (2021)

Neuroimaging glutamatergic mechanisms differentiating antipsychotic treatment-response
por: Mouchlianitis, Elias D., et al.
Publicado: (2023)

Author Correction: Neuroimaging glutamatergic mechanisms differentiating antipsychotic treatment-response
por: Mouchlianitis, Elias D., et al.
Publicado: (2023)

T125. INCIDENCE OF TREATMENT RESISTANCE SCHIZOPHRENIA IN A COMMUNITY SAMPLE USING THE TRRIP CONCENSUS
por: Joyce, Dan, et al.
Publicado: (2018)

Neural correlates of positive and negative symptoms through the illness course: an fMRI study in early psychosis and chronic schizophrenia
por: Vanes, Lucy D., et al.
Publicado: (2019)

Neural correlates of reward processing in healthy siblings of patients with schizophrenia
por: Hanssen, Esther, et al.
Publicado: (2015)

M106. VIRTUAL-REALITY COGNITIVE TRAINING AND ASSESSMENT IN SCHIZOPHRENIA
por: Porffy, Lilla, et al.
Publicado: (2020)

F155. THE NEUROPHYSIOLOGICAL AND BEHAVIOURAL EFFECTS OF TRANSCRANIAL DIRECT CURRENT STIMULATION ON WORKING MEMORY AND EXECUTIVE FUNCTIONING IN SCHIZOPHRENIA
por: Orlov, Natasza, et al.
Publicado: (2018)

Cognitive correlates of abnormal myelination in psychosis
por: Vanes, Lucy D., et al.
Publicado: (2019)

Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia
por: Evans, Simon, et al.
Publicado: (2012)

Clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report
por: Sanchez, Asiel Yair Adan, et al.
Publicado: (2016)

Clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report — ADDENDUM
por: Sanchez, Asiel Yair Adan, et al.
Publicado: (2019)

F77. OXYTOCIN ENHANCES VISUAL ATTENTION TO FACIAL STIMULI IN PATIENTS WITH SCHIZOPHRENIA: EVIDENCE FROM AN EYE-TRACKING STUDY
por: Porffy, Lilla, et al.
Publicado: (2018)

Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report
por: Patel, Sachin S, et al.
Publicado: (2010)

Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: A review of the literature
por: Patel, Sachin S, et al.
Publicado: (2010)

T148. THALAMIC-CORTICAL CONNECTIVITY IN PATIENTS WITH AUDITORY HALLUCINATIONS IN SCHIZOPHRENIA
por: Zaytseva, Yulia, et al.
Publicado: (2018)

Vortioxetine as adjunctive therapy in the treatment of schizophrenia
por: Redaelli, Sofia, et al.
Publicado: (2022)

Targeting Treatment-Resistant Auditory Verbal Hallucinations in Schizophrenia with fMRI-Based Neurofeedback – Exploring Different Cases of Schizophrenia
por: Dyck, Miriam S., et al.
Publicado: (2016)

T150. REAL-TIME FMRI NEUROFEEDBACK TO DOWN-REGULATE SUPERIOR TEMPORAL GYRUS ACTIVITY IN PATIENTS WITH SCHIZOPHRENIA AND AUDITORY HALLUCINATIONS: A PROOF-OF-CONCEPT STUDY
por: Orlov, Natasza, et al.
Publicado: (2018)

A Novel Virtual Reality Assessment of Functional Cognition: Validation Study
por: Porffy, Lilla Alexandra, et al.
Publicado: (2022)

Alpha3/alpha2 power ratios relate to performance on a virtual reality shopping task in ageing adults
por: Patchitt, Joel, et al.
Publicado: (2022)

M148. NORMALIZATION IN REWARD PROCESSING DURING INITIAL TREATMENT MAY PREDICT LONG-TERM CLINICAL OUTCOME IN ANTIPSYCHOTIC NAïVE SCHIZOPHRENIA PATIENTS
por: Nielsen, Mette, et al.
Publicado: (2020)

Emotion recognition and oxytocin in patients with schizophrenia
por: Averbeck, B. B., et al.
Publicado: (2012)

A systematic review of TMS and neurophysiological biometrics in patients with schizophrenia
por: di Hou, Meng, et al.
Publicado: (2021)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

The role of cognitive control in the positive symptoms of psychosis
por: Horne, Charlotte M., et al.
Publicado: (2022)

S129. DOES TREATMENT RESISTANT SCHIZOPHRENIA PRESENT A CHARACTERISTIC SYMPTOMATIC SIGNATURE?
por: Bertolucci, Bruno, et al.
Publicado: (2018)

S123. TREATMENT RESISTANT SCHIZOPHRENIA AND GYRIFICATION-BASED CONNECTOME
por: Ajnakina, Olesya, et al.
Publicado: (2018)

Ultra-treatment-resistant Schizophrenia. A case report
por: Osca Oliver, A., et al.
Publicado: (2022)

Treatment of early resistant schizophrenia: a case report
por: Benhammou, S., et al.
Publicado: (2023)

T147. DECREASED STRIATAL REWARD PREDICTION ERROR CODING IN UNMEDICATED SCHIZOPHRENIA PATIENTS
por: Katthagen, Teresa, et al.
Publicado: (2018)

The importance of pro-social processing, and ameliorating dysfunction in schizophrenia. An FMRI study of oxytocin
por: Wigton, Rebekah, et al.
Publicado: (2021)

S128. CORRELATION OF DURATION OF UNTREATED PSYCHOSIS WITH TREATMENT RESPONSE ON THE SYMPTOM DIMENSIONS OF SCHIZOPHRENIA
por: Elias, Beatriz Yukie, et al.
Publicado: (2018)

A symptom-based approach to treatment of psychosis in autism spectrum disorder
por: Bell, Victoria, et al.
Publicado: (2018)

148 HPV, HIV, and Cancer: A Global Challenge
por: Franceschi, Silvia
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gi8l15m0vb39f51028ddskrk9d